Corrigendum: Predicting the Effects of CYP2C19 and Carboxylesterases on Vicagrel, a Novel P2Y12 Antagonist, by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Approach.

Article Details

Citation
Copy to clipboard

Liu S, Wang Z, Tian X, Cai W

Corrigendum: Predicting the Effects of CYP2C19 and Carboxylesterases on Vicagrel, a Novel P2Y12 Antagonist, by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Approach.

Front Pharmacol. 2021 Apr 16;12:668861. doi: 10.3389/fphar.2021.668861. eCollection 2021.

PubMed ID
33935793 [ View in PubMed
]
Abstract

[This corrects the article DOI: 10.3389/fphar.2020.591854.].

DrugBank Data that Cites this Article

Drug Targets
DrugTargetKindOrganismPharmacological ActionActions
VicagrelP2Y purinoceptor 12ProteinHumans
Unknown
Antagonist
Inhibitor
Details